Literature DB >> 20653654

'Insignificant' prostate cancer on prostatectomy and cystoprostatectomy: variation on a theme 'low-volume/low-grade' prostate cancer?

Kiril Trpkov1, Asli Yilmaz, Tarek A Bismar, Rodolfo Montironi.   

Abstract

Although 'insignificant' prostate cancer has been examined separately in radical prostatectomy (RP) and radical cystoprostatectomy (RCP) studies, it is not entirely clear whether cancers designated as 'insignificant' on RP and RCP represent the same, similar or different forms of prostate cancer. Insignificant prostate cancer has been traditionally defined based on the pathological findings in the whole prostate gland. In addition to the pathological determinants of 'insignificant' prostate cancer, it is also important to account for the biological and the clinical context of the disease, as well as patient age and health status to designate a prostate cancer 'insignificant'. This review examines and compares prostate cancers described as 'insignificant' on RP and RCP. We conclude that in most cases these low-volume/low-grade prostate cancers represent an early stage and clinically 'silent' disease, which are only detected in different clinical settings.

Entities:  

Mesh:

Year:  2010        PMID: 20653654     DOI: 10.1111/j.1464-410X.2010.09499.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  6 in total

1.  Many young men with prostate-specific antigen (PSA) screen-detected prostate cancers may be candidates for active surveillance.

Authors:  Jeri Kim; James Ebertowski; Matthew Janiga; Jorge Arzola; Gayle Gillespie; Michael Fountain; Douglas Soderdahl; Edith Canby-Hagino; Sally Elsamanoudi; Jennifer Gurski; John W Davis; Patricia A Parker; Douglas D Boyd
Journal:  BJU Int       Date:  2013-01-25       Impact factor: 5.588

2.  [Active surveillance for low-risk prostate cancer].

Authors:  Annika Herlemann; Christian G Stief
Journal:  Urologe A       Date:  2016-02       Impact factor: 0.639

3.  Incidentally found prostate cancer and influence on overall survival after radical cystoprostatectomy.

Authors:  Algimantas Sruogis; Albertas Ulys; Giedre Smailyte; Zygimantas Kardelis; Arunas Kulboka; Giedre Anglickienė; Nerimantas Samalavicius; Marius Anglickis
Journal:  Prostate Cancer       Date:  2012-06-03

4.  Can microfocal prostate cancer be regarded as low-risk prostate cancer?

Authors:  Seung Hwan Lee; Kyu Hyun Kim; Jae Hyuk Choi; Kyo Chul Koo; Dong Hoon Lee; Byung Ha Chung
Journal:  Prostate Int       Date:  2013-12-30

5.  Changes in risk-group stratification of patients undergoing radical prostatectomy at the Southern Alberta Institute of Urology over time.

Authors:  Benjamin Shiff; Premal Patel; Kiril Trpkov; Geoffrey T Gotto
Journal:  Res Rep Urol       Date:  2019-03-20

6.  Prostate-Specific Antigen (PSA) Screening and New Biomarkers for Prostate Cancer (PCa).

Authors:  Carsten Stephan; Harry Rittenhouse; Xinhai Hu; Henning Cammann; Klaus Jung
Journal:  EJIFCC       Date:  2014-04-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.